Group_NNP cash_NN ow_NN statement_NN 12_CD months_NNS to_TO 12_CD months_NNS to_TO 31_CD Dec_NNP 2002_CD 31_CD Dec_NNP 2001_CD Notes_NNP m_FW m_FW Net_JJ cash_NN inow_NN from_IN operating_VBG activities_NNS before_IN exceptional_JJ items_NNS 31_CD 345.5_CD 342.3_CD Exceptional_JJ items_NNS 12.0_CD Net_JJ cash_NN inow_NN from_IN operating_VBG activities_NNS 31_CD 345.5_CD 354.3_CD Dividend_NN received_VBN from_IN joint_JJ venture_NN 5.4_CD 4.8_CD Returns_NNS on_IN investments_NNS and_CC servicing_NN of_IN finance_NN Interest_NN paid_VBD 9.2_CD 19.7_CD Interest_NN received_VBD 4.9_CD 10.3_CD Dividends_NNS paid_VBN by_IN subsidiary_NN undertakings_NNS to_TO minority_NN interests_NNS 1.7_CD 1.7_CD 6.0_CD 11.1_CD Taxation_NNP 57.2_CD 47.6_CD Capital_NN expenditure_NN and_CC financial_JJ investment_NN Purchase_NN of_IN tangible_JJ xed_JJ assets_NNS 143.4_CD 91.6_CD Purchase_NN of_IN intangible_JJ xed_JJ assets_NNS 4.8_CD 10.2_CD Sales_NNS of_IN tangible_JJ xed_JJ assets_NNS 1.3_CD 22.1_CD Purchase_NN of_IN trade_NN investments_NNS 3.4_CD 4.9_CD Cash_NN received_VBN on_IN disposal_NN of_IN investment_NN in_IN Nycomed_NNP Pharma_NNP 123.0_CD Costs_NNS associated_VBN with_IN disposal_NN of_IN investment_NN in_IN Nycomed_NNP Pharma_NNP 3.5_CD 4.9_CD Sale_NNP of_IN trade_NN investments_NNS 1.4_CD 152.4_CD 33.5_CD Acquisitions_NNS and_CC disposals_NNS Purchase_NN of_IN 45_CD %_NN minority_NN in_IN Amersham_NNP Biosciences_NNP 24_CD 704.1_CD Costs_NNS associated_VBN with_IN the_DT purchase_NN of_IN 45_CD %_NN minority_NN in_IN Amersham_NNP Biosciences_NNP 24_CD 4.5_CD Other_JJ acquisitions_NNS 40.6_CD 4.9_CD Other_JJ disposals_NNS 1.0_CD 749.2_CD 3.9_CD Equity_NNP dividends_NNS paid_VBD 51.6_CD 41.7_CD Net_JJ cash_NN ow_NN before_IN management_NN of_IN liquid_JJ resources_NNS and_CC nancing_VBG 665.5_CD 288.3_CD Management_NN of_IN liquid_JJ resources_NNS 32,33_CD 74.5_CD 91.4_CD Financing_NN Issue_NN of_IN share_NN capital_NN 25_CD 413.2_CD 16.2_CD Costs_NNS associated_VBN with_IN issue_NN of_IN share_NN capital_NN 5.5_CD Loans_NNPS and_CC finance_NN leases_NNS 32,33_CD 161.9_CD 205.3_CD Repayment_NN of_IN long_JJ term_NN loan_NN 32,33_CD 13.6_CD Capital_NN contribution_NN by_IN minority_NN interest_NN in_IN Amersham_NNP Biosciences_NNP 8.7_CD 564.7_CD 189.1_CD Cash_NN ow_NN in_IN the_DT year_NN 32,33_CD 26.3_CD 7.8_CD Analysis_NN of_IN free_JJ cash_NN ow_NN before_IN exceptional_JJ items_NNS Free_JJ cash_NN ow_NN from_IN :_: Operating_NN activities_NNS before_IN exceptional_JJ items_NNS 31_CD 345.5_CD 342.3_CD Dividend_NN received_VBN from_IN joint_JJ venture_NN 5.4_CD 4.8_CD Returns_NNS on_IN investments_NNS and_CC servicing_NN of_IN finance_NN 6.0_CD 11.1_CD Taxation_NNP 57.2_CD 47.6_CD Free_NNP cash_NN ow_NN after_IN taxation_NN and_CC returns_NNS on_IN investments_NNS and_CC servicing_NN of_IN finance_NN 287.7_CD 288.4_CD Capital_NN expenditure_NN and_CC financial_JJ investment_NN prior_RB to_TO the_DT disposal_NN of_IN Nycomed_NNP Pharma_NNP 148.9_CD 84.6_CD Free_NNP cash_NN ow_NN before_IN equity_NN dividends_NNS 138.8_CD 203.8_CD Free_NNP cash_NN ow_NN after_IN equity_NN dividends_NNS 87.2_CD 162.1_CD Liquid_NN resources_NNS are_VBP dened_VBN as_IN short_JJ term_NN deposits_NNS with_IN banks_NNS and_CC current_JJ asset_NN investments_NNS in_IN bonds_NNS and_CC equities_NNS ._.
These_DT total_JJ 22.1_CD m_NN 2001_CD 96.5_CD m_NN and_CC are_VBP shown_VBN in_IN the_DT balance_NN sheet_NN within_IN the_DT total_NN of_IN short_JJ term_NN deposits_NNS and_CC investments_NNS ._.
54_CD Amersham_NNP plc_NN Annual_JJ Report_NNP &_CC Accounts_NNPS 2002_CD
